This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Danone's Food May Be Healthy but Its Stock Is Not

NEW YORK ( TheStreet) -- The French food company Danone SA (OTC: DANOY) has long been known as the maker of yogurt, including the Activia, Oikos and Ser brands.

But this company also has a healthy business in flavored and vitamin-enriched water under its Evian and Aqua brands, among many others, and a medical nutrition division. It is in this area where several competitors, including Nestle (OTC: NSRGY) and the American Mead Johnson Nutrition (MJN) are trying to eat Danone's lunch.

Danone's American depositary receipts are not so healthy. They have an average three-month daily volume of over 1,042,000, although on Tuesday volume was less than 136,000 shares. They closed down 1.2% to $13.77 Tuesday and are down 5.2% for the year to date.

Shares of Danone have corrected almost 15% from its 52-week high of $16.12 to Tuesday's closing price, and are selling at less than 17 times forward (1year) earnings. This is a big company with a market cap of over $40 billion, but if its shares keep tumbling it will soon challenge the 52-week low of $13.29.

What's the problem with this company's stock? After all, it is one of the first food companies to manufacture and market a yogurt with pro-biotic bacteria that could be categorized as a "medical food."

And its Medical Nutrition division, which markets primarily under the Nutricia brand, provides specialized food for people receiving medical treatment, babies afflicted with certain illnesses and the frail elderly. Its products include liquid oral nutritional supplements, hypoallergenic products and oral and feeding tube food products for the dietary treatment of infants and children, among many others.

However, the U.S. Food and Drug Administration, on its Web site, classifies medical food in quite a different way.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,071.22 -41.93 -0.24%
S&P 500 1,977.80 -5.05 -0.25%
NASDAQ 4,505.8520 -6.3420 -0.14%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs